Abstract
Organized breast cancer (BC) screening in France by mammography every 2 years in women aged 50–74 years is regularly criticized, over hypothetical adverse effects, overdiagnosis or overtreatment. We assessed the screening impact on initial tumor features, treatments and outcomes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
